Minimally Invasive Surgical Instruments Market by Product (Handheld Instruments, Inflation Devices, Surgical Scopes), Type of Surgery (Cardiothoracic, Gastrointestinal, Orthopedic, Urological), End User (Hospitals, ASCs), Region (2022 - 2026)
[274 Pages Report] The global minimally invasive surgical instruments market is projected to reach USD 28.9 billion by 2026, at a CAGR of 7.4%. The rapidly increasing number of surgeries is accelerating the global demand for minimally invasive surgical instruments. Also, the growing number of ASCs and rising interest in outpatient robotic-assisted surgeries provide enormous opportunities for players in the minimally invasive surgical instruments market.
To know about the assumptions considered for the study, Request for Free Sample Report
COVID-19 Impact on Global Minimally Invasive Surgical Instruments Market
The emergence of the COVID-19 pandemic has changed the delivery of medical care across the world. The increased pressure due to the growing rate of hospitalization of COVID-19 patients had led to the re-profiling of many hospitals and departments for treating patients with COVID-19. Consequently, many elective surgeries were canceled or postponed worldwide to reserve or redirect the available limited capacities and resources (like hospital beds and patient care professionals) toward COVID-19 patient care.
Moreover, the provision of cardiac surgeries has been disproportionally affected due to the reallocation of intensive care resources. According to a comprehensive analysis of a Society of Thoracic Surgeons (STS) database, cardiac surgery volumes in the US fell by more than half during the COVID-19 pandemic’s first wave, with the biggest drops observed in the New England and mid-Atlantic regions. Cardiac surgery services have undergone structural remodeling into a centralized system to continue provisions of emergency surgery alongside hospital management of COVID-19 patients. Although these measures have been beneficial for supporting the focused management of COVID-19 patients, it is important to reflect upon the future consequences of delayed elective cardiac surgery. Patients with cardiac complications are likely to have progressive conditions. These conditions could require minimally invasive treatment involving handheld instruments, surgical scopes, and cutting instruments, thereby supporting the market growth. Moreover, from 2019–2020, the procedural volume for cardiac surgery declined substantially, but it is expected to increase post-pandemic 2021 due to the backlog emerging from this delay. This is expected further to drive the demand for minimally invasive surgical instruments market.
Market Dynamics
Driver: Advantages of MIS over open surgical techniques
Over the years, minimally invasive surgeries (MIS) have undergone a drastic transformation in technological advancements, which has brought about a paradigm shift in the way surgical procedures are performed in operating rooms. Most surgeons currently opt for advanced minimally invasive surgical procedures such as laparo-endo single-incision surgery (LESS) due to their advantages over traditional open surgical techniques. These advantages include fewer scars and tissue injury, quicker recovery periods, shorter hospital stays, reduced blood loss and trauma, lower risk of infection, and reduced overall healthcare costs. In addition, minimally invasive surgeries are increasingly being covered by health insurance providers in select countries. These factors have led to an increased preference for minimally invasive surgeries among patients.
Opportunity: Emerging markets
Emerging economies such as India, South Korea, Malaysia, Vietnam, Africa, and Middle Eastern countries such as Israel, Saudi Arabia, and the UAE offer significant growth opportunities to major market players. This can be attributed to their low regulatory barriers, improvements in healthcare infrastructure, growing patient population, and rising healthcare expenditure. In addition, the regulatory policies in the Asia Pacific region are more adaptive and business-friendly than those in developed countries. This, along with the increasing competition in mature markets, has drawn key players in the minimally invasive surgical instruments market to focus on emerging countries.
Restraint: Changing regulatory landscape in the medical device industry
The regulatory environment is extremely uncertain for medical device manufacturers. From 2005 to 2010, the average time taken to approve a 510 (k) application increased by 43%, while the time required to obtain a premarket approval increased by 75%. The US FDA demands more clinical data with respect to the clinical safety and efficacy of a product. This leads to increased investments by companies in clinical trials, delays in the approval process, and additional capital requirements for in-depth post-marketing surveillance studies. It also increases the risk of product recalls, especially when companies lack the funds to conduct additional studies to support additional data requirements from the FDA. These delays in approvals also restrain the growth of the minimally invasive surgical instruments market. Such regulatory reforms also restrict small manufacturers from entering the market.
Challenge: Shortage of trained professionals
The minimally invasive surgical instruments market is highly consolidated. The top players— Medtronic plc (Ireland), Johnson & Johnson (US), Stryker Corporation (US), Abbott Laboratories, Inc. (US), and Boston Scientific Corporation (US)-in the minimally invasive surgical instruments market accounted for a combined majority market share in 2020. There is a high degree of competition among the market players. Only major companies can afford high-capital investments as well as the high cost of R&D and manufacturing. This will prevent new entrants from entering this market.
“Electrosurgical & electrocautery instruments segment to register the highest growth rate during the forecast period”
The minimally invasive surgical instruments market is segmented into handheld instruments, inflation devices, surgical scopes, cutting instruments, guiding devices, electrosurgical & electrocautery instruments, and other instruments based on product. Electrosurgical & electrocautery instruments are expected to be the fastest-growing product segment during the forecast period owing to their high acceptance among physicians for controlling blood loss during surgical procedures.
“In 2020, cardiothoracic surgery segment accounted for the largest share in the market, by type of surgery”
The minimally invasive surgical instruments market is segmented into cardiothoracic surgery, gastrointestinal surgery, orthopedic surgery, gynecological surgery, cosmetic & bariatric surgery, urological surgery, and other surgeries based on type of surgery. In 2020, the cardiothoracic surgery segment accounted for the largest share of the minimally invasive surgical instruments market. The increasing prevalence of CVD coupled with the growing awareness about the benefits of early detection of cardiovascular complications contributes to the growth of this segment.
“In 2020, hospitals and specialty clinics segment accounted for the largest share in the market, by end user”
The minimally invasive surgical instruments market is segmented into hospitals and specialty clinics and ambulatory surgery centers. In 2020, the hospitals and specialty clinics segment accounted for the largest share of the minimally invasive surgical instruments market. The adoption of minimally invasive surgical instruments is higher in hospitals and specialty clinics, owing to their higher purchasing power, highly skilled healthcare professionals, and access to technologically developed surgical facilities. However, the costs incurred by patients for minimally invasive surgeries in a hospital inpatient or outpatient facilities are higher compared to ASCs. As a result, the preference for ASC treatment is also rising.
“North America commanded the largest share of the minimally invasive surgical instruments market in 2020”
The global minimally invasive surgical instruments market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the minimally invasive surgical instruments market. The North American minimally invasive surgical instruments market growth can be attributed to the high adoption of innovative minimally invasive surgical among medical professionals and the large number of manufacturing companies that have an established base or are headquartered in the US.
To know about the assumptions considered for the study, download the pdf brochure
Some key players in the minimally invasive surgical instruments market (2022- 2026)
- Medtronic plc (Ireland)
- Johnson & Johnson (US)
- Stryker Corporation (US)
- Abbott Laboratories, Inc. (US)
- Boston Scientific Corporation (US)
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
Request Sample Scope of the Report
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
|
Report Metric |
Details |
|
Market size available for years |
2019–2026 |
|
Base year considered |
2020 |
|
Forecast period |
2022–2026 |
|
Forecast units |
Value (USD) |
|
Segments covered |
Product, type of surgery, end user, and region |
|
Geographies covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
|
Companies covered |
Medtronic plc (Ireland), Johnson & Johnson (US), Stryker Corporation (US), Abbott Laboratories, Inc. (US), Boston Scientific Corporation (US), B. Braun Melsungen AG (Germany), CONMED Corporation (US), Smith & Nephew plc (UK), Zimmer Biomet Holdings, Inc. (US), Becton, Dickinson and Company (US), The Cooper Companies Inc. (US), HOYA Corporation (Japan), Surgical Innovations Group plc (UK), Koninklijke Philips N.V. (Netherlands), FUJIFILM Holdings Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Applied Medical Resources Corporation (US), KLS Martin Group (Germany), Scanlan International, Inc. (US), Wexler Surgical (US), STRAUSS SURGICAL (US), AMNOTEC International Medical GmbH (Germany), EndoMed Systems GmbH (Germany), TROKAMED GmbH (Germany), and Surgical Holdings (UK). |
This report categorizes the minimally invasive surgical instruments market into the following segments and subsegments:
By Product
- Handheld Instruments
- Graspers
- Retractors/Elevators
- Suturing Instruments
- Dilators
- Other Handheld Instruments
- Inflation Devices
- Balloons
- Balloon Inflation Devices
- Surgical Scopes
- Laparoscopes
- Urology Endoscopes
- Arthroscopes
- Neuroendoscopes
- Other Surgical Scopes
- Cutting Instruments
- Trocars
- Other Cutting Instruments
- Guiding Devices
- Guiding Catheters
- Guidewires
- Electrosurgical & Electrocautery Instruments
- Electrosurgical Instruments
- Electrocautery Devices
- Other Instruments
By Type of Surgery
- Cardiothoracic Surgery
- Gastrointestinal Surgery
- Orthopedic Surgery
- Gynecological Surgery
- Cosmetic & Bariatric Surgery
- Urological Surgery
- Other Surgeries
By End User
- Hospitals and Specialty Clinics
- Ambulatory Surgery Centers
By Region
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Recent Developments
- In March 2021, Johnson & Johnson (US) launched its ECHELON+ Stapler.
- In June 2019, Medtronic plc (Ireland) acquired Titan Spine (Germany). This acquisition strengthened Medtronic’s position as a leading innovator in procedural solutions for spine surgery.
- In November 2018, Stryker Corporation (US) acquired K2M Group to strengthen and expand its product offerings in the arthroscopy and minimally invasive spine portfolio and expand its manufacturing capabilities.
Frequently Asked Questions (FAQ):
What are the different types of minimally invasive surgical instruments used?
Based on product, the minimally invasive surgical instruments market is segmented into handheld instruments, inflation devices, surgical scopes, cutting instruments, guiding devices, electrosurgical & electrocautery instruments, and other instruments. The handheld instruments segment accounted for the largest share of the minimally invasive surgical instruments market in 2020, mainly due to the increasing number of surgical procedures, the low cost of articulating laparoscopic handheld surgical instruments, and the rising technological innovations in handheld instruments.
Who are the major end users of minimally invasive surgical instruments?
The minimally invasive surgical instruments market is segmented into hospitals and specialty clinics and ambulatory surgery centers based on end user. In 2020, the hospitals and specialty clinics segment accounted for the largest share of the minimally invasive surgical instruments market. The large number of minimally invasive surgical procedures performed in hospitals due to the presence of highly skilled healthcare professionals is driving the growth of this segment.
What are the factors driving the minimally invasive surgical instruments market?
Growth in minimally invasive surgical instruments market is mainly driven by factors such as the increasing number of surgical procedures worldwide, the advantages of MIS over open surgical techniques, and the increasing adoption of advanced robotics in ASCs.
Who are the key players operating in the minimally invasive surgical instruments market?
This is market is dominated by Medtronic plc (Ireland), Johnson & Johnson (US), Stryker Corporation (US), Abbott Laboratories, Inc. (US), Boston Scientific Corporation (US), B. Braun Melsungen AG (Germany), CONMED Corporation (US), Smith & Nephew plc (UK), Zimmer Biomet Holdings, Inc. (US), Becton, Dickinson and Company (US), The Cooper Companies Inc. (US), HOYA Corporation (Japan), Surgical Innovations Group plc (UK), Koninklijke Philips N.V. (Netherlands), and FUJIFILM Holdings Corporation (Japan).
Which geographical region is dominating in minimally invasive surgical instruments market?
The global minimally invasive surgical instruments market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the minimally invasive surgical instruments market. The large share of North America in this market can be attributed to the increasing prevalence of chronic disorders, increasing healthcare spending, and the highly developed healthcare system in the US and Canada. However, the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period. The high growth in this market can be attributed to the rising geriatric population in several APAC countries (coupled with the increasing prevalence of chronic disorders), increasing healthcare spending, increasing government efforts to increase awareness about early disease detection, growing per capita income, expansion of private-sector hospitals to rural areas in various APAC countries, and the presence of high-growth markets in the region. The low labor costs and the favorable regulatory environment in this region are also expected to propel market growth. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 23)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.2.2 MARKETS COVERED
FIGURE 1 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SEGMENTATION
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 29)
2.1 RESEARCH DATA
2.2 RESEARCH APPROACH
FIGURE 2 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: RESEARCH DESIGN
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
2.2.2.1 Primary sources
2.2.2.2 Key data from primary sources
2.2.2.3 Key industry insights
2.2.2.4 Breakdown of primary interviews
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET)
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.1.1 Approach 1: Company revenue estimation approach
FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
2.3.1.2 Approach 2: Presentations of companies and primary interviews
2.3.1.3 Growth forecast
2.3.1.4 CAGR projections
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3.2 TOP-DOWN APPROACH
FIGURE 7 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE
2.6 ASSUMPTIONS FOR THE STUDY
2.7 LIMITATIONS
2.8 RISK ASSESSMENT
2.8.1 RISK ASSESSMENT: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET
2.9 GROWTH RATE ASSUMPTIONS
2.10 COVID-19 HEALTH ASSESSMENT
2.11 COVID-19 ECONOMIC ASSESSMENT
2.12 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 9 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 10 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
2.13 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET
3 EXECUTIVE SUMMARY (Page No. - 46)
FIGURE 11 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 12 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2021 VS. 2026 (USD MILLION)
FIGURE 13 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 14 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)
4 PREMIUM INSIGHTS (Page No. - 50)
4.1 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET OVERVIEW
FIGURE 15 THE GROWING PREVALENCE OF TARGET DISEASES AND THE INCREASING NUMBER OF SURGERIES WORLDWIDE DRIVE THE MARKET GROWTH
4.2 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SHARE, BY PRODUCT, 2021 VS. 2026
FIGURE 16 THE HANDHELD INSTRUMENTS SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2026
4.3 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SHARE, BY TYPE OF SURGERY, 2021 VS. 2026
FIGURE 17 CARDIOTHORACIC SURGERY SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
4.4 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SHARE, BY END USER, 2021 VS. 2026
FIGURE 18 HOSPITALS AND SPECIALTY CLINICS SEGMENT TO CONTINUE TO DOMINATE THE MARKET IN 2026
4.5 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 19 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 53)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 20 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing number of surgical procedures worldwide
TABLE 1 PERCENTAGE INCREASE IN NUMBER OF SURGERIES PERFORMED IN THE US
TABLE 2 NUMBER OF MINIMALLY INVASIVE LAPAROSCOPIC COLECTOMY PROCEDURES, BY COUNTRY/REGION (2014-2018)
TABLE 3 NUMBER OF MINIMALLY INVASIVE LAPAROSCOPIC APPENDECTOMY PROCEDURES, BY COUNTRY/REGION (2014-2018)
TABLE 4 NUMBER OF MINIMALLY INVASIVE LAPAROSCOPIC CHOLECYSTECTOMY PROCEDURES, BY COUNTRY/REGION (2014-2018)
TABLE 5 NUMBER OF MINIMALLY INVASIVE LAPAROSCOPIC INGUINAL HERNIA REPAIR PROCEDURES, BY COUNTRY/REGION (2014-2018)
TABLE 6 NUMBER OF MINIMALLY INVASIVE LAPAROSCOPIC HYSTERECTOMY PROCEDURES, BY COUNTRY/REGION, 2014-2018
5.2.1.2 Advantages of MIS over open surgical techniques
5.2.2 RESTRAINTS
5.2.2.1 Changing regulatory landscape in the medical device industry
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets
5.2.3.2 Increasing adoption of advanced robotics in ASCs
5.2.4 CHALLENGES
5.2.4.1 High degree of market consolidation
5.3 IMPACT OF COVID-19 ON THE MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET
5.4 PESSIMISTIC, OPTIMISTIC, AND REALISTIC SCENARIOS
5.4.1 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET
FIGURE 21 PESSIMISTIC SCENARIO
FIGURE 22 OPTIMISTIC SCENARIO
FIGURE 23 REALISTIC SCENARIO
5.5 PRICING ANALYSIS
TABLE 7 PRICE OF MINIMALLY INVASIVE SURGICAL INSTRUMENTS (2021)
5.6 PATENT ANALYSIS
5.6.1 PATENT ANALYSIS OF SUTURING INSTRUMENTS
5.6.2 PATENT ANALYSIS OF ELECTROSURGICAL INSTRUMENTS
5.7 TRADE ANALYSIS
5.7.1 TRADE ANALYSIS FOR NEEDLES, CATHETERS, AND CANNULAS
TABLE 8 IMPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAS, BY COUNTRY, 2016–2020 (USD MILLION)
TABLE 9 EXPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAS, BY COUNTRY, 2016–2020 (USD MILLION)
5.8 VALUE CHAIN ANALYSIS
FIGURE 24 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASE
5.9 SUPPLY CHAIN ANALYSIS
FIGURE 25 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: SUPPLY CHAIN ANALYSIS
5.10 ECOSYSTEM ANALYSIS OF THE MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET
FIGURE 26 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: ECOSYSTEM ANALYSIS
5.10.1 ROLE IN ECOSYSTEM
5.11 PORTER’S FIVE FORCES ANALYSIS
TABLE 10 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.11.1 THREAT OF NEW ENTRANTS
5.11.2 THREAT OF SUBSTITUTES
5.11.3 BARGAINING POWER OF BUYERS
5.11.4 BARGAINING POWER OF SUPPLIERS
5.11.5 DEGREE OF COMPETITION
5.12 REGULATORY LANDSCAPE
5.12.1 NORTH AMERICA
5.12.1.1 US
5.12.1.2 Canada
5.12.2 EUROPE
5.12.3 ASIA PACIFIC
5.12.3.1 Japan
5.12.3.2 India
5.12.4 LATIN AMERICA
5.12.4.1 Brazil
5.12.4.2 Mexico
5.12.5 MIDDLE EAST
5.13 CASE STUDY ANALYSIS
5.13.1 CASE STUDY 1
5.13.2 CASE STUDY 2
5.14 TECHNOLOGY ANALYSIS
5.15 TRENDS/DISRUPTIONS IMPACTING THE BUSINESS OF CUSTOMERS
5.15.1 REVENUE SOURCES ARE SHIFTING TOWARDS TECHNOLOGY-BASED SOLUTIONS DUE TO THE COVID-19 PANDEMIC
5.15.2 REVENUE SHIFT FOR THE MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET
6 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT (Page No. - 77)
6.1 INTRODUCTION
TABLE 11 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 12 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE, 2019–2026 (MILLION UNITS)
6.2 HANDHELD INSTRUMENTS
6.2.1 PRIMARY NOTES
6.2.1.1 Key industry insights
TABLE 13 KEY PRODUCTS IN THE HANDHELD INSTRUMENTS MARKET
TABLE 14 HANDHELD INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 15 HANDHELD INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.2.2 GRASPERS
6.2.2.1 Increasing focus on patient safety to drive the market growth
TABLE 16 KEY PRODUCTS IN THE GRASPERS MARKET
TABLE 17 GRASPERS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.3 RETRACTORS/ELEVATORS
6.2.3.1 The growing number of spinal, orthopedic, and endoscopic surgical procedures to support the adoption of retractors/elevators
TABLE 18 KEY PRODUCTS IN THE RETRACTORS/ELEVATORS MARKET
TABLE 19 RETRACTORS/ELEVATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.4 SUTURING INSTRUMENTS
6.2.4.1 The shortage of skilled professionals for the handling of sutures is a key factor restraining the market growth of this segment
TABLE 20 KEY PRODUCTS IN THE SUTURING INSTRUMENTS MARKET
TABLE 21 SUTURING INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.5 DILATORS
6.2.5.1 Dilators assist in making a tunnel through an incision, thus providing clear images of internal organs
TABLE 22 DILATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.6 OTHER HANDHELD INSTRUMENTS
TABLE 23 KEY PRODUCTS IN THE OTHER HANDHELD INSTRUMENTS MARKET
TABLE 24 OTHER HANDHELD INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3 INFLATION DEVICES
TABLE 25 INFLATION DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 26 INFLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.3.1 BALLOONS
6.3.1.1 The growing number of angioplasty procedures to drive the growth of this market segment
TABLE 27 BALLOONS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.2 BALLOON INFLATION DEVICES
6.3.2.1 Balloon inflation devices provide safe dilation with minimum mucosal strain
TABLE 28 BALLOON INFLATION DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.4 SURGICAL SCOPES
TABLE 29 KEY PRODUCTS IN THE SURGICAL SCOPES MARKET
TABLE 30 SURGICAL SCOPES MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 31 SURGICAL SCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 32 SURGICAL SCOPES MARKET, BY TYPE, 2019–2026 (MILLION UNITS)
6.4.1 LAPAROSCOPES
6.4.1.1 The increasing number of laparoscopic surgeries and reduction in the overall surgery cost drive the growth of the market
TABLE 33 KEY PRODUCTS IN THE LAPAROSCOPES MARKET
6.4.2 UROLOGY ENDOSCOPES
6.4.2.1 The growing prevalence of urinary tract infections is expected to increase the number of urology endoscopic procedures
6.4.3 ARTHROSCOPES
6.4.3.1 Increasing prevalence of rheumatoid arthritis and hip & knee arthroscopy to drive the growth of this segment
TABLE 34 KEY PRODUCTS IN THE ARTHROSCOPES MARKET
6.4.4 NEUROENDSCOPES
6.4.4.1 The increasing prevalence of brain cancer drives the demand for neuroendoscopy procedures
6.4.5 OTHER SURGICAL SCOPES
6.5 CUTTING INSTRUMENTS
TABLE 35 KEY PRODUCTS IN THE CUTTING INSTRUMENTS MARKET
TABLE 36 CUTTING INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 37 CUTTING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.5.1 TROCARS
6.5.1.1 Improved trocar designs result in reduced complication- a key factor driving the market growth of this segment
TABLE 38 KEY PRODUCTS IN THE TROCARS MARKET
TABLE 39 TROCARS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.5.2 OTHER CUTTING INSTRUMENTS
TABLE 40 KEY PRODUCTS IN THE OTHER CUTTING INSTRUMENTS MARKET
TABLE 41 OTHER CUTTING INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.6 GUIDING DEVICES
TABLE 42 GUIDING DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 43 GUIDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.6.1 GUIDING CATHETERS
6.6.1.1 The availability of customized catheters for specific inventions is driving the growth of this segment
TABLE 44 KEY PRODUCTS IN THE GUIDING CATHETERS MARKET
TABLE 45 GUIDING CATHETERS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.6.2 GUIDEWIRES
6.6.2.1 Efficient guiding and tracking capabilities of guidewires drives its adoption for complex surgeries
TABLE 46 KEY PRODUCTS IN THE GUIDEWIRES MARKET
TABLE 47 GUIDEWIRES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.7 ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS
TABLE 48 KEY PRODUCTS IN THE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET
TABLE 49 ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 50 ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.7.1 ELECTROSURGICAL INSTRUMENTS
6.7.1.1 Electrosurgical instruments are expected to grow at the highest CAGR during the forecast period
TABLE 51 KEY PRODUCTS IN THE ELECTROSURGICAL INSTRUMENTS MARKET
TABLE 52 ELECTROSURGICAL INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.7.2 ELECTROCAUTERY DEVICES
6.7.2.1 Increasing number of plastic surgeries to drive the market growth for electrocautery devices
TABLE 53 ELECTROCAUTERY DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.8 OTHER INSTRUMENTS
TABLE 54 KEY PRODUCTS IN THE OTHER INSTRUMENTS MARKET
TABLE 55 OTHER INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
7 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY (Page No. - 112)
7.1 INTRODUCTION
TABLE 56 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2019–2026 (USD MILLION)
7.2 CARDIOTHORACIC SURGERY
7.2.1 THE GROWING BURDEN OF CVD IS A KEY FACTOR DRIVING THE MARKET GROWTH
TABLE 57 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR CARDIOTHORACIC SURGERY, BY REGION, 2019–2026 (USD MILLION)
7.3 GASTROINTESTINAL SURGERY
7.3.1 THE INCREASING PREVALENCE OF COLORECTAL CANCER IS EXPECTED TO DRIVE THE GROWTH OF THIS SEGMENT
TABLE 58 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR GASTROINTESTINAL SURGERY, BY REGION, 2019–2026 (USD MILLION)
7.4 ORTHOPEDIC SURGERY
7.4.1 THE INCREASING GERIATRIC POPULATION AND THE SUBSEQUENT INCREASE IN ORTHOPEDIC AILMENTS IS EXPECTED TO DRIVE THE GROWTH OF THIS SEGMENT
TABLE 59 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR ORTHOPEDIC SURGERY, BY REGION, 2019–2026 (USD MILLION)
7.5 GYNECOLOGICAL SURGERY
7.5.1 THE GROWING NUMBER OF LAPAROSCOPIC HYSTERECTOMIES PERFORMED IS EXPECTED TO SUPPORT THE MARKET GROWTH
TABLE 60 LAPAROSCOPIC HYSTERECTOMY PROCEDURES PERFORMED IN HOSPITALS (PER 100,000 INHABITANTS), BY COUNTRY, 2013 VS. 2018
TABLE 61 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR GYNECOLOGICAL SURGERY, BY REGION, 2019–2026 (USD MILLION)
7.6 COSMETIC & BARIATRIC SURGERY
7.6.1 INCREASING PREVALENCE OF OBESITY AND GROWING PREFERENCE FOR COSMETIC PROCEDURES TO DRIVE THE MARKET GROWTH
TABLE 62 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR COSMETIC & BARIATRIC SURGERY, BY REGION, 2019–2026 (USD MILLION)
7.7 UROLOGICAL SURGERY
7.7.1 INCREASING PREVALENCE OF UROLOGIC CANCERS TO DRIVE THE ADOPTION OF MIS FOR THIS SEGMENT
TABLE 63 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR UROLOGICAL SURGERY, BY REGION, 2019–2026 (USD MILLION)
7.8 OTHER SURGERIES
TABLE 64 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR OTHER SURGERIES, BY REGION, 2019–2026 (USD MILLION)
8 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER (Page No. - 124)
8.1 INTRODUCTION
TABLE 65 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2019–2026 (USD MILLION)
8.2 HOSPITALS AND SPECIALTY CLINICS
8.2.1 THE INCREASING NUMBER OF HOSPITALS AND GOVERNMENT INVESTMENTS TO DRIVE THE GROWTH OF THIS SEGMENT
TABLE 66 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR HOSPITALS AND SPECIALTY CLINICS, BY REGION, 2019–2026 (USD MILLION)
8.3 AMBULATORY SURGERY CENTERS (ASCS)
8.3.1 LOWER COSTS AND SHORTER PATIENT STAYS TO PROPEL THE GROWTH OF THIS END-USER SEGMENT
8.3.2 PRIMARY NOTES
8.3.2.1 Key industry insights
TABLE 67 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR ASCS, BY REGION, 2019–2026 (USD MILLION)
9 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY REGION (Page No. - 129)
9.1 INTRODUCTION
TABLE 68 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 27 NORTH AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SNAPSHOT
TABLE 69 NORTH AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 70 NORTH AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 71 NORTH AMERICA: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 72 NORTH AMERICA: INFLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 73 NORTH AMERICA: CUTTING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 74 NORTH AMERICA: GUIDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 75 NORTH AMERICA: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 76 NORTH AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2019–2026 (USD MILLION)
TABLE 77 NORTH AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2019–2026 (USD MILLION)
TABLE 78 NORTH AMERICA: ENDOSCOPIC GASTROINTESTINAL SURGERY MARKET FOR ESOPHAGEAL STRICTURES, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 79 NORTH AMERICA: ENDOSCOPIC GASTROINTESTINAL SURGERY MARKET FOR ENDOSCOPIC STRICTURES, BY END USER, 2018–2025 (USD MILLION)
TABLE 80 NORTH AMERICA: GASTROINTESTINAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 81 NORTH AMERICA: HANDHELD INSTRUMENTS FOR GASTROINTESTINAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 82 NORTH AMERICA: INFLATION DEVICES FOR GASTROINTESTINAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 83 NORTH AMERICA: GASTROINTESTINAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2018–2025 (USD MILLION)
9.2.1 US
9.2.1.1 The US dominated the North American minimally invasive surgical instruments market in 2020
TABLE 84 US: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 85 US: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 86 US: INFLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 87 US: CUTTING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 88 US: GUIDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 89 US: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 90 US: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2019–2026 (USD MILLION)
TABLE 91 US: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Increasing prevalence of cancer and the rising incidence of IBD drive the market growth in Canada
TABLE 92 CANADA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 93 CANADA: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 94 CANADA: INFLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 95 CANADA: CUTTING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 96 CANADA: GUIDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 97 CANADA: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 98 CANADA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2019–2026 (USD MILLION)
TABLE 99 CANADA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3 EUROPE
TABLE 100 EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 101 EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 102 EUROPE: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 103 EUROPE: INFLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 104 EUROPE: CUTTING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 105 EUROPE: GUIDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 106 EUROPE: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 107 EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2019–2026 (USD MILLION)
TABLE 108 EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 A well-established healthcare system in Germany is expected to boost the use of medical devices, inclusive of MIS instruments
TABLE 109 GERMANY: KEY MACROINDICATORS
TABLE 110 GERMANY: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 111 GERMANY: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 112 GERMANY: INFLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 113 GERMANY: CUTTING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 114 GERMANY: GUIDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 115 GERMANY: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 116 GERMANY: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2019–2026 (USD MILLION)
TABLE 117 GERMANY: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.2 UK
9.3.2.1 High incidence of cancer in the UK to boost the adoption of MIS instruments
TABLE 118 UK: KEY MACROINDICATORS
TABLE 119 UK: MINIMALLY INVASIVE INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 120 UK: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 121 UK: INFLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 122 UK: CUTTING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 123 UK: GUIDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 124 UK: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 125 UK: MINIMALLY INVASIVE INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2019–2026 (USD MILLION)
TABLE 126 UK: MINIMALLY INVASIVE INSTRUMENTS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 An increasing number of hip & knee surgeries in France is expected to drive the market growth for MIS instruments
TABLE 127 FRANCE: KEY MACROINDICATORS
TABLE 128 FRANCE: MINIMALLY INVASIVE INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 129 FRANCE: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 130 FRANCE: INFLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 131 FRANCE: CUTTING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 132 FRANCE: GUIDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 133 FRANCE: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 134 FRANCE: MINIMALLY INVASIVE INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2019–2026 (USD MILLION)
TABLE 135 FRANCE: MINIMALLY INVASIVE INSTRUMENTS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Increasing incidence of chronic conditions to drive the market growth in Italy
TABLE 136 ITALY: MINIMALLY INVASIVE INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 137 ITALY: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 138 ITALY: INFLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 139 ITALY: CUTTING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 140 ITALY: GUIDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 141 ITALY: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 142 ITALY: MINIMALLY INVASIVE INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2019–2026 (USD MILLION)
TABLE 143 ITALY: MINIMALLY INVASIVE INSTRUMENTS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Increasing incidence of CVD to boost the adoption of MIS and drive the overall market growth in Spain
TABLE 144 SPAIN: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 145 SPAIN: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 146 SPAIN: INFLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 147 SPAIN: CUTTING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 148 SPAIN: GUIDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 149 SPAIN: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 150 SPAIN: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2019–2026 (USD MILLION)
TABLE 151 SPAIN: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 152 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP)
TABLE 153 ROE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 154 ROE: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 155 ROE: INFLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 156 ROE: CUTTING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 157 ROE: GUIDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 158 ROE: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 159 ROE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2019–2026 (USD MILLION)
TABLE 160 ROE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 28 ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SNAPSHOT
TABLE 161 ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 162 ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 163 ASIA PACIFIC: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 164 ASIA PACIFIC: INFLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 165 ASIA PACIFIC: CUTTING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 166 ASIA PACIFIC: GUIDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 167 ASIA PACIFIC: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 168 ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2019–2026 (USD MILLION)
TABLE 169 ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.1 CHINA
9.4.1.1 China dominated the APAC market for MIS instruments in 2020
TABLE 170 CHINA: KEY MACROINDICATORS
TABLE 171 CHINA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 172 CHINA: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 173 CHINA: INFLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 174 CHINA: CUTTING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 175 CHINA: GUIDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 176 CHINA: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 177 CHINA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2019–2026 (USD MILLION)
TABLE 178 CHINA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Rising geriatric population in Japan to increase the prevalence of chronic conditions, supporting market growth in Japan
TABLE 179 JAPAN: KEY MACROINDICATORS
TABLE 180 JAPAN: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 181 JAPAN: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 182 JAPAN: INFLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 183 JAPAN: CUTTING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 184 JAPAN: GUIDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 185 JAPAN: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 186 JAPAN: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2019–2026 (USD MILLION)
TABLE 187 JAPAN: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Healthcare infrastructure improvements and increasing geriatric population to drive the market growth in India
TABLE 188 INDIA: KEY MACROINDICATORS
TABLE 189 INDIA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 190 INDIA: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 191 INDIA: INFLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 192 INDIA: CUTTING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 193 INDIA: GUIDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 194 INDIA: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 195 INDIA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2019–2026 (USD MILLION)
TABLE 196 INDIA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
TABLE 197 ROAPAC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 198 ROAPAC: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 199 ROAPAC: INFLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 200 ROAPAC: CUTTING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 201 ROAPAC: GUIDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 202 ROAPAC: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 203 ROAPAC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2019–2026 (USD MILLION)
TABLE 204 ROAPAC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 INCREASING HEALTHCARE EXPENDITURE AND EFFORTS TO IMPLEMENT UNIVERSAL HEALTH COVERAGE IN THE REGION TO SUPPORT MARKET GROWTH
TABLE 205 LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 206 LATIN AMERICA: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 207 LATIN AMERICA: INFLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 208 LATIN AMERICA: CUTTING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 209 LATIN AMERICA: GUIDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 210 LATIN AMERICA: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 211 LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2019–2026 (USD MILLION)
TABLE 212 LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 STRENGTHENING OF HEALTHCARE INFRASTRUCTURE IN THE REGION TO SUPPORT THE MARKET GROWTH FOR MIS
TABLE 213 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 214 MIDDLE EAST & AFRICA: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 215 MIDDLE EAST & AFRICA: INFLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 216 MIDDLE EAST & AFRICA: CUTTING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 217 MIDDLE EAST & AFRICA: GUIDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 218 MIDDLE EAST & AFRICA: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 219 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2019–2026 (USD MILLION)
TABLE 220 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2019–2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 202)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN THE MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET
TABLE 221 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MINIMALLY INVASIVE SURGICAL INSTRUMENTS MANUFACTURING COMPANIES
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 29 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET
10.4 MARKET SHARE ANALYSIS
FIGURE 30 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SHARE, BY KEY PLAYER (2020)
TABLE 222 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: DEGREE OF COMPETITION
10.5 COMPANY EVALUATION QUADRANT
10.5.1 LIST OF EVALUATED VENDORS
10.5.2 STARS
10.5.3 EMERGING LEADERS
10.5.4 PERVASIVE PLAYERS
10.5.5 PARTICIPANTS
FIGURE 31 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
10.6 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES (2020)
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES
FIGURE 32 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2020
10.7 COMPETITIVE BENCHMARKING
10.7.1 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS
FIGURE 33 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF TOP PLAYERS IN THE MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET
TABLE 223 PRODUCT FOOTPRINT OF COMPANIES
TABLE 224 REGIONAL FOOTPRINT OF COMPANIES
10.8 COMPETITIVE SCENARIO
10.8.1 PRODUCT LAUNCHES
TABLE 225 KEY PRODUCT LAUNCHES
10.8.2 DEALS
TABLE 226 KEY DEALS
10.8.3 OTHER DEVELOPMENTS
TABLE 227 KEY OTHER DEVELOPMENTS
11 COMPANY PROFILES (Page No. - 214)
11.1 KEY PLAYERS
(Business overview, Products offered, Recent Developments, MNM view)*
11.1.1 MEDTRONIC PLC
TABLE 228 MEDTRONIC PLC: BUSINESS OVERVIEW
FIGURE 34 MEDTRONIC PLC: COMPANY SNAPSHOT (2020)
11.1.2 JOHNSON & JOHNSON
TABLE 229 JOHNSON & JOHNSON: BUSINESS OVERVIEW
FIGURE 35 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2020)
11.1.3 STRYKER CORPORATION
TABLE 230 STRYKER CORPORATION: BUSINESS OVERVIEW
FIGURE 36 STRYKER CORPORATION: COMPANY SNAPSHOT (2020)
11.1.4 BOSTON SCIENTIFIC CORPORATION
TABLE 231 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
FIGURE 37 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020)
11.1.5 ABBOTT LABORATORIES, INC.
TABLE 232 ABBOTT LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 38 ABBOTT LABORATORIES, INC.: COMPANY SNAPSHOT (2020)
11.1.6 B. BRAUN MELSUNGEN AG
TABLE 233 B.BRAUN MELSUNGEN AG.: BUSINESS OVERVIEW
FIGURE 39 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2020)
11.1.7 CONMED CORPORATION
TABLE 234 CONMED CORPORATION: BUSINESS OVERVIEW
FIGURE 40 CONMED CORPORATION: COMPANY SNAPSHOT (2020)
11.1.8 SMITH & NEPHEW PLC
TABLE 235 SMITH & NEPHEW PLC: BUSINESS OVERVIEW
FIGURE 41 SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2020)
11.1.9 ZIMMER BIOMET HOLDINGS, INC.
TABLE 236 ZIMMER BIOMET HOLDINGS, INC.: BUSINESS OVERVIEW
FIGURE 42 ZIMMER BIOMET HOLDINGS, INC.: COMPANY SNAPSHOT (2020)
11.1.10 BECTON, DICKINSON AND COMPANY
TABLE 237 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 43 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS
11.2.1 THE COOPER COMPANIES INC.
11.2.2 HOYA CORPORATION
11.2.3 SURGICAL INNOVATIONS GROUP PLC
11.2.4 KONINKLIJKE PHILIPS N.V.
11.2.5 FUJIFILM HOLDINGS CORPORATION
11.2.6 KARL STORZ SE & CO. KG
11.2.7 APPLIED MEDICAL RESOURCES CORPORATION
11.2.8 KLS MARTIN GROUP
11.2.9 SCANLAN INTERNATIONAL, INC.
11.2.10 WEXLER SURGICAL
11.2.11 STRAUSS SURGICAL
11.2.12 AMNOTEC INTERNATIONAL MEDICAL GMBH
11.2.13 ENDOMED SYSTEMS GMBH
11.2.14 TROKAMED GMBH
11.2.15 SURGICAL HOLDINGS
12 APPENDIX (Page No. - 267)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
This study involved four major activities in estimating the current size of the minimally invasive surgical instruments market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate segments and subsegments' market size.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the minimally invasive surgical instruments market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research
- The revenues generated by leading players operating in the minimally invasive surgical instruments market have been determined through primary and secondary research
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Global Minimally Invasive Surgical Instruments Market Size: Top-Down Approach
Data Triangulation
After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Report Objectives
- To define, describe, segment, and forecast the global minimally invasive surgical instruments market by product, type of surgery, end user, and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall minimally invasive surgical instruments market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies2
- To track and analyze company developments such as product launches, agreements, partnerships, and acquisitions in the minimally invasive surgical instruments market
- To benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Country Information
- Minimally invasive surgical instruments market size and growth rate estimates for countries in the Rest of Europe, the Rest of Asia Pacific, Latin America, and Middle East & Africa
Company profiles
- Additional five company profiles of players operating in the minimally invasive surgical instruments market.
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Minimally Invasive Surgical Instruments Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Minimally Invasive Surgical Instruments Market
What are the emerging technological innovations in the Minimally Invasive Surgical Instruments Market?
In what way the COVID19 is impacting the global growth of Minimally Invasive Surgical Instruments Market?
Which of the geographical segment is expected major share in the global Minimally Invasive Surgical Instruments Market?